Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Mecamylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB4 known ✓ | P30926 | 4/20 | 0.95 |
| ▸ | CHRNA3 known ✓ | P32297 | 4/20 | 0.95 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.95 |
| ▸ | CHRNA7 | P36544 | 4/20 | 0.95 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.95 |
| ▸ | CHRNA1 | P02708 | 3/20 | 0.95 |
| ▸ | CHRNG | P07510 | 3/20 | 0.95 |
| ▸ | CHRNB1 | P11230 | 3/20 | 0.95 |
| ▸ | CHRND | Q07001 | 3/20 | 0.95 |
| ▸ | LMNA | P02545 | 1/20 | 0.95 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.95 |
| ▸ | PKM | P14618 | 1/20 | 0.95 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.95 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.95 |
| ▸ | THPO | P40225 | 1/20 | 0.95 |
| ▸ | CHRNE | Q04844 | 1/20 | 0.95 |
| ▸ | CHRNA2 | Q15822 | 1/20 | 0.95 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mecamylamine SCHEMBL592362 | 1.00 | CHRNB2 (0.95) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| Mecamylamine SCHEMBL3007951 | 0.97 | CHRNB2 (1.00) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| Dexmecamylamine SCHEMBL29376444 | 0.97 | CHRNB2 (1.00) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| Mecamylamine SCHEMBL34253 | 0.97 | CHRNB2 (1.00) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| Mecamylamine SCHEMBL11028235 | 0.97 | CHRNB2 (1.00) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| Mecamylamine SCHEMBL3008785 | 0.97 | CHRNB2 (1.00) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| Mecamylamine SCHEMBL34252 | 0.97 | CHRNB2 (1.00) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| Mecamylamine SCHEMBL7208020 | 0.97 | CHRNB2 (1.00) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| Mecamylamine SCHEMBL4416036 | 0.97 | CHRNB2 (1.00) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| 2(R)-Mecamylamine SCHEMBL308575 | 0.97 | CHRNB2 (1.00) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8710682-B2 | Materials and methods for stress reduction in semiconductor wafer passivation layers | Designer Molecules Inc, Inc. (US) | 2014-04-29 | — | — | US | disclosed |
| US-20130228901-A1 | MATERIALS AND METHODS FOR STRESS REDUCTION IN SEMICONDUCTOR WAFER PASSIVATION LAYERS | DESIGNER MOLECULES, INC. (US) | 2013-09-05 | — | — | US | disclosed |
| US-7157587-B2 | Imide-extended liquid bismaleimide resin | DESIGNER MOLECULES, INC. (US) | 2007-01-02 | — | — | US | disclosed |
| US-20040225059-A1 | Imide-extended liquid bismaleimide resin | DESIGNER MOLECULES, INC. | 2004-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040225059-A1 | Imide-extended liquid bismaleimide resin | PBRM1, MSI2, BCAT2 | CHRNB4 2869/4885CHRNA3 2566/4885CHRNB2 3258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.